
Hill Research is a company leveraging Generative AI to accelerate the last mile of clinical trials for pharmaceutical companies. Their business model includes providing data, software, services, and an extensive ecosystem to support critical functions from R&D through commercial stages. Their key product, TheraGPT, is an extensible agentic AI platform that automates and optimizes clinical trial workflows such as CRF annotation, patient recruitment, compliance, and data analysis, achieving up to 20x faster task completion and 98%+ accuracy. The platform uses a multi-agent large language model (LLM) tree to enable pharmaceutical companies to shorten clinical trial cycles, streamline operations, and increase drug approval success rates. Hill Research has won awards such as the 2025 Venture Contest for International Entrepreneurs and has been featured in various industry events and press releases, indicating traction and recognition in the life sciences AI market.

Hill Research is a company leveraging Generative AI to accelerate the last mile of clinical trials for pharmaceutical companies. Their business model includes providing data, software, services, and an extensive ecosystem to support critical functions from R&D through commercial stages. Their key product, TheraGPT, is an extensible agentic AI platform that automates and optimizes clinical trial workflows such as CRF annotation, patient recruitment, compliance, and data analysis, achieving up to 20x faster task completion and 98%+ accuracy. The platform uses a multi-agent large language model (LLM) tree to enable pharmaceutical companies to shorten clinical trial cycles, streamline operations, and increase drug approval success rates. Hill Research has won awards such as the 2025 Venture Contest for International Entrepreneurs and has been featured in various industry events and press releases, indicating traction and recognition in the life sciences AI market.